Bausch Health
BHC
#3918
Rank
S$4.25 B
Marketcap
S$11.39
Share price
28.76%
Change (1 day)
48.78%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): S-$3.78

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is S-$3.77. In 2025 the company made an earnings per share (EPS) of S$0.54 an increase over its 2024 EPS that were of S-$0.15.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$3.78-804.04%
2025S$0.54-450%
2024S-$0.15-92.59%
2023S-$2.07160.89%
2022S-$0.79-76.64%
2021S-$3.4068.45%
2020S-$2.02-68.91%
2019S-$6.49-57.11%
2018S-$15.12-272.22%
2017S$8.78-199.29%
2016S-$8.84798.7%
2015S-$0.98-128.31%
2014S$3.48-204.62%
2013S-$3.32602.7%
2012S-$0.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
S-$0.12-96.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S-$1.21-67.80%๐Ÿ‡บ๐Ÿ‡ธ USA